Business Context and Reporting Period
This Form 8-K is a current report filed by WellPoint, Inc. (now known as Elevance Health, Inc.) on February 8, 2005. The report discloses material definitive agreements regarding executive and director compensation effective as of February 2, 2005.
Key Financial Metrics
The filing does not provide consolidated financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics for the company. The only financial data disclosed relates to specific cash incentive payments to named executive officers for the 2004 performance year:
- Larry C. Glasscock: $2,057,878
- Keith R. Faller: $776,413
- Thomas G. Snead Jr.: $754,523
- David R. Frick: $678,602
- Michael L. Smith: $678,602
Material Changes
The filing reports two primary corporate actions:
- Executive Incentive Awards: The Compensation Committee authorized annual incentive awards for 2004 under the Anthem Annual Incentive Plan, based on company and individual performance measures.
- Director Compensation Program: The Board of Directors adopted a new compensation program for non-employee directors, replacing or supplementing prior arrangements.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, management commentary on future operations, or discussion of risks and contingencies. The document is strictly a disclosure of completed compensation actions and the adoption of a new director compensation policy.
Investor Verification Checklist
- Verify the total cash outflow for the 2004 executive incentive awards against the company's 2004 Annual Report (10-K).
- Review the attached Exhibit 99.1 to understand the specific structure and value of the new non-employee director compensation program.
- Confirm the performance metrics used to calculate the 2004 executive awards as approved in the first quarter of 2004.